Argenica Therapeutics Ltd
AGN
Company Profile
Business description
Argenica Therapeutics Ltd is engaged in the research and development of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and its non-clinical studies to other indications and regulatory consultants.
Contact
117 Broadway
Unit 4
NedlandsWA6009
AUST: +61 893293396
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
stocks
Our Tesla fair value increases meaningfully
Progress on Robotaxi and Optimus shows real world AI growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,244.90 | 1.60 | 0.02% |
| CAC 40 | 8,071.36 | 4.68 | 0.06% |
| DAX 40 | 24,309.46 | 513.33 | -2.07% |
| Dow JONES (US) | 48,972.05 | 43.55 | -0.09% |
| FTSE 100 | 10,171.76 | 17.33 | 0.17% |
| HKSE | 27,968.09 | 141.18 | 0.51% |
| NASDAQ | 23,530.76 | 326.69 | -1.37% |
| Nikkei 225 | 53,375.60 | 16.89 | 0.03% |
| NZX 50 Index | 13,360.02 | 52.85 | -0.39% |
| S&P 500 | 6,939.31 | 38.72 | -0.55% |
| S&P/ASX 200 | 8,943.40 | 20.20 | 0.23% |
| SSE Composite Index | 4,157.98 | 6.75 | 0.16% |